Cancer Treatment
New research from Italy, the United States and the United Kingdom in the area of cancer treatment detailed
Published in Women's Health Weekly, May 15th, 2006
Study 1: The antitumor activity of NGR-tumor necrosis factor (TNF) in combination with various chemotherapeutic drugs was studied.
According to recent research published in the journal Clinical Cancer Research, "Subnanogram doses of NGR-TNF, a TNF-alpha derivative able to target tumor neovessels, can enhance the antitumor activity of doxorubicin and melphalan in murine models. We have examined the antitumor activity of NGR-TNF in combination with various chemotherapeutic drugs acting via different mechanisms, including, besides...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Lower breast cancer progression from benign breast disease may be linked to aspirin use - Cancer Mortality
Bilateral salpingo-oophorectomy reduces overall, but not cancer-specific, mortality - Familial Obesity
Weight gain prevention program proves effective in high-risk women with familial obesity - Osteoporosis
Bone fracture incidence is increased in women with pollen-allergy and is related to obesity - Osteoporosis
Osteoporosis risk may be identifiable through dental panoramic radiographs - Allergy & Immunology
Childhood food allergies may be influenced by maternal fish consumption during pregnancy - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
